Analysis of national Medicare Advantage enrollment data between 2022 and 2023 shows that Medicare Advantage gained more than two million enrollees, reaching more than 47% of the Medicare eligible population. Medicare Fee-For-Service enrollment data showed 800,000 fewer enrollees over the same period. Special Needs Plans (SNPs) also saw growth, with more than 1,300 plans serving over five million beneficiaries in 2023.
Recent Work
Pharma Innovation and the IRA: Report on the Top 19 Companies from the First Half of 2023
Since the Inflation Reduction Act (IRA) was passed in 2022, significant discussion has been devoted to its potential consequences for the development of new drugs. This report examines whether the IRA has had immediate impacts on drug development in the first half of 2023 through analysis of the companies’ R&D investments and M&A and licensing activities.
Read More
Read More
Advancing Nonmedical Supplemental Benefits in Medicare Advantage
Since 2019, ATI Advisory and the Long-Term Quality Alliance, with support from The SCAN Foundation, have led national efforts to advance person-centered, non-medical supplemental benefits in Medicare Advantage.
Read More
Read More
Opportunities to Improve Health Equity in Long Term Services and Supports (LTSS) Through Medicare
Beneficiaries who are Black or Latino/a are more likely than white beneficiaries to report difficulty with activities of daily living (ADLs) and other conditions that can negatively impact their health. Understanding the experiences of individuals reporting difficulty with ADLs across race and ethnicity can help policymakers develop strategies to address inequities. This databook, supported by the Robert Wood Johnson Foundation, conveys research findings on the racial and ethnic disparities among this population across social determinants of health, natural community supports, and health care experiences.
Read More
Read More